KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer

BACKGROUND/AIMS: The predictive and prognostic value of KRAS mutation and its type of mutations in non-small cell lung cancer (NSCLC) are controversial. This clinical study was designed to investigate the predictive value of KRAS mutations and its mutation types to pemetrexed and gemcitabine based t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Korean J Intern Med
Main Authors: Park, Sehhoon, Kim, Ji-Yeon, Lee, Se-Hoon, Suh, Beomseok, Keam, Bhumsuk, Kim, Tae Min, Kim, Dong-Wan, Heo, Dae Seog
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association of Internal Medicine 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5432792/
https://ncbi.nlm.nih.gov/pubmed/28407465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2015.299
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados